Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

2(50.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 2(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05377554Phase 3Completed

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

Role: lead

NCT06227585Phase 2Completed

Feasibility and Efficacy Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery

Role: lead

NCT04420689Phase 1Completed

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Role: lead

NCT06662097Phase 2Recruiting

A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Role: lead

All 4 trials loaded